|
Caraco Pharmaceutical Laboratories |
|
|
1150 Elijah McCoy Drive Detroit, MI 48202 USA phone:(313) 871-8400 fax:(313) 871-8314
|
|
| Symbol |
CPD |
| Exchange |
AMEX |
| Founded |
0 |
| Employees |
128 |
|
|
| www.caraco.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Generic and private label prescription and over-the-counter pharmaceuticals. |
 |
| Management |
| Daniel Movens, CEO; Mukul Rathi, Interim CFO; Robert Kurkiewicz, Sr. Vice President Regulatory Affairs; Gurpartap Singh, Sr. Vice President, Business Strategies; Jayesh Shah, Director Commercial; Akin-Remi Ajac-Ayodele, Director; David Risk, Director- Business Development; Tammy Bitterman, CBM, Director - Human Resources; Thomas Versosky, Director - Business Strategies |
| |
|
|
|
|
|
|
|
| Keywords |
| central nervous system, cardiology, pain management, Diabetes, blood sugar, diabetic, metabolic, insulin, over the counter, OTC, PainManagement |
|
|
|
| Description |
|
Caraco Pharmaceutical Laboratories, Ltd. is developing, manufacturing and marketing generic and private label prescription and over-the-counter pharmaceuticals in the United States. |
 |
| Products / Services |
The Company's product portfolio includes 14 prescription products: Guaifenesin LA, Metroprolol Tartrate, Miraphen PSE, Paromomycin Sulfate, Salsalate, CMT, Guai/DM, Clonazepam, Flurbiprofen, Carbamazepine, Oxaprozin, Metformin Hydrochloride, Tramadol Hydrochloride and Miraphen PE. The Company's drugs relate to a variety of therapeutic segments, including the central nervous system, cardiology, pain management and diabetes.
|
 |
 |
|
|
|
|
|
|